Home > Insider Trading > Filing (0001214659-16-010591)

Filing Details

Accession Number:: 0001214659-16-010591
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-31 17:41:00
Reporting Period:: 2016-03-29

Filing Date:: 2016-03-31
Accepted Time:: 2016-03-31 17:41:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1387713	Neulion Inc.	NLN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188070	B Charles Wang	Neulion, Inc. 1600 Old Country Road Plainview NY 11803		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-29	63,930	$0.78	13,075,791	No	4	P	Direct
Common Stock	Acquisiton	2016-03-29	1,500,000	$0.87	14,575,791	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	22,820,650	Indirect	By AvantaLion LLC
Common Stock	128,020	Indirect	By trust for benefit of grandchild
Common Stock	128,020	Indirect	By trust for benefit of grandchild
Common Stock	15,534,956	Indirect	By JK&B Capital V Special Opportunity Fund, L.P.
Common Stock	40,206,096	Indirect	By spouse
Restricted Common Stock	750,000	Indirect	By spouse
Restricted Common Stock	750,000	Indirect	By spouse

Footnotes

Mr. Wang purchased these shares from J. Christopher Wagner, the Executive Vice President, Marketplace Strategy, of NeuLion.
The purchase price of each share was $0.7821, which was the 5 day volume weighted average price of NeuLion's common stock on the Toronto Stock Exchange ending March 28, 2016.
Multiple same-way open market purchases effected on the same day within a one dollar price range are reported on this line. The figure in the price column is the weighted average purchase price for these transactions. These trades were executed on the Aequitas NEO Exchange, Alpha ATS, Nasdaq CX, Nasdaq CX2, TriAct MATCH Now, Omega ATS, Canadian Securities Exchange and the Toronto Stock Exchange, and the purchase prices were in Canadian dollars. The purchase price per share for each trade was between Cdn$1.09 and Cdn$1.16. The purchase prices were converted to US dollars by the executing broker, Merrill Lynch, at a rate of 0.7591. The reporting person undertakes to provide, upon request by the Commission staff, NeuLion, Inc., or a security holder of NeuLion, Inc., full information regarding the number of shares purchased at each separate price.
AvantaLion LLC is a Delaware limited liability company controlled by Mr. Wang.
Mr. Wang is the trustee for the two trusts and his grandchildren are the beneficiaries of the trusts.
JK&B Capital V Special Opportunity Fund, L.P. is a limited partnership that is not controlled by Mr. Wang, who has a pecuniary interest of 85% in such fund.
Mr. Wang disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mr. Wang is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The reporting person's spouse was granted these restricted shares subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The restricted shares vest at a rate of one-quarter of their allotted amount per year over four years. Vesting began on March 7, 2016.
The reporting person's spouse was granted these restricted shares subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The restricted shares vest at a rate of one-quarter of their allotted amount per year over four years. Vesting began on May 18, 2015.